alexa The Importance of Planned Dose of Chemotherapy on Time: Do We Need to Change Our Clinical Practice?

Author(s): Foote M

Abstract Share this page

Abstract INTRODUCTION: Dose-limiting hematological toxicity is encountered with many chemotherapy regimens; it is common clinical practice to reduce the dosage or delay the administration of the next cycle of chemotherapy in response to toxicity [1, 2]. Reducing or delaying the dose, however, will reduce the dose intensity of treatment. This practice may achieve some reduction in toxicity, but may also decrease the therapeutic effect of the treatment. This review will examine the evidence for a relationship between reductions in dose intensity of treatment and suboptimal outcome, as distinct from studies seeking to improve survival by using dose-intensified chemotherapy regimens.
This article was published in Oncologist and referenced in

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Recommended Journals

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version